News
Big shakeups may be coming to the childhood vaccination schedule. Here's a look at some of the shots that could be subject to ...
1don MSN
Merck & Co., Inc. (MRK) Launches $3B Plan to Reinvest Ahead of Keytruda Patent Expiry in 2028
We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Merck & Co., Inc. stands third ...
Coupled with headwinds in China, Merck is also seeing lower demand for Gardasil in Japan. Sales are expected to remain weak in Japan in the second half of 2025. Our estimates for Gardasil sales ...
Zacks.com on MSN14h
MRK Posts Cholesterol Drug Data, Focus Shifts Back to Its Pipeline
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
The global Vaccines Market, valued at US$59.52 billion in 2024, stood at US$50.46 billion in 2025 and is projected to advance at a resilient ...
Pfizer (NYSE: PFE) has become a tantalizing yet potentially perilous option for dividend investors. With its stock price down ...
The global Vaccines Market, valued at US$59.52 billion in 2024, stood at US$50.46 billion in 2025 and is projected to advance at a ...
The pharmaceutical giant currently offers a 7% yield, but dividend investors need to look beyond the headline number.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback